Perceived Feasibility and Acceptability of HIV Prevention Research With Daily Oral PrEP Among Young Transgender Women (YTGW) Who Sell or Trade Sex in Bangkok and Pattaya, Thailand
- PMID: 39189957
- PMCID: PMC11574323
- DOI: 10.1521/aeap.2024.36.4.244
Perceived Feasibility and Acceptability of HIV Prevention Research With Daily Oral PrEP Among Young Transgender Women (YTGW) Who Sell or Trade Sex in Bangkok and Pattaya, Thailand
Abstract
Young transgender women (YTGW) who sell or trade sex have among the highest HIV incidence rates in Thailand. Using qualitative methods, we assessed perceived acceptability, feasibility, and optimal design of a combination HIV prevention intervention including PrEP for YTGW. Key informant interviews were conducted during July 2016-July 2018 with 21 YTGW, aged 18-26 years, who sold sex and resided in Bangkok or Pattaya, Thailand. Grounded theory and content analysis were used for data analysis. Most YTGW interviewed reported high interest in HIV prevention research and believed participation in it supported sexual health. However, participants perceived HIV studies as complicated and time-consuming. Regarding PrEP, participants suggested more PrEP options beyond daily oral PrEP and expressed concerns related to perceived side effects of PrEP, including interaction with gender-affirming hormone therapy. Improving PrEP knowledge, being able to self-assess HIV risk, and reducing HIV/PrEP stigma could increase interest in research and PrEP uptake among YTGW.
Keywords: HIV; PrEP; Thailand; sex trade; transgender women; young.
References
-
- Bureau of AIDS, TB, and STIs. (2017). Thailand National Guidelines on HIV/AIDS Treatment and Prevention 2017. Thailand Ministry of Public Health, Department of Disease Control, Nonthaburi.
-
- Centers for Disease Control and Prevention. (2021). Preexposure Prophylaxis for the Prevention of HIV Infection in the United States – 2021 Update – A Clinical Practice Guideline US Public Health Service: PREEXPOSURE PROPHYLAXIS FOR THE PREVENTION OF HIV INFECTION IN THE UNITED STATES – 2021 UPDATE, A CLINICAL PRACTICE GUIDELINE (cdc.gov)
-
- Centers for Disease Control and Prevention. (2024). Clinical Guidance for PrEP: Considerations for specific populations. Retrieved August 6, 2024, from HYPERLINK “https://www.cdc.gov/hivnexus/hcp/prep/index.html”Clinical Guidance for PrEP | HIV Nexus | CDC
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous